(3,5-Diphenylphenyl)boronic acid | CAS:128388-54-5

We serve (3,5-Diphenylphenyl)boronic acid CAS:128388-54-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
(3,5-Diphenylphenyl)boronic acid

Chemical Name:(3,5-Diphenylphenyl)boronic acid
CAS.NO:128388-54-5
Synonyms:[1,1':3',1''-Terphenyl]-5'-ylboronic acid
5'-m-Terphenylboronic Acid;
(3,5-Diphenylphenyl)boronic acid;
1,1':3',1''-Terphenyl-5'-boronic acid
3,5-BPBA
Molecular Formula:C18H15BO2
Molecular Weight:274.12200
 
Physical and Chemical Properties:
Density:1.211
Melting point:292-296ºC
Boiling point:513.022ºC
Index of Refraction:1.652
 
Specification:
Appearance:White to off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:OLED intermediates



Contact us for information like (3,5-Diphenylphenyl)boronic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3,5-BPBA physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,1′:3′,1”-Terphenyl-5′-boronic acid Use and application,1,1′:3′,1”-Terphenyl-5′-boronic acid technical grade,usp/ep/jp grade.


Related News: Capacity: the bottleneck of business growth, expanding capacity and increasing utilization become a trend. Capacity is the core factor that determines the supply capacity of API companies. Insufficient capacity will cause companies to selectively complete orders and produce varieties, limiting the expansion of API products and market development.1,2,6,7-tetrahydrocyclopenta[e][1]benzofuran-8-one manufacturer Capacity: the bottleneck of business growth, expanding capacity and increasing utilization become a trend. Capacity is the core factor that determines the supply capacity of API companies. Insufficient capacity will cause companies to selectively complete orders and produce varieties, limiting the expansion of API products and market development.TRITYL ISOTHIOCYANATE supplier The US National Institutes of Health is working on a preventative vaccine, but it will likely take a few months until the first phase of clinical trials get underway, and more than a year until a vaccine might be available, according to experts.3-[3-(trifluoromethyl)phenyl]propanal vendor Analogous to master cell lines used to manufacture biopharmaceutical drug products such as monoclonal antibodies, clonal master iPSC lines are a renewable source for manufacturing cell therapy products which are well-defined and uniform in composition, can be mass produced at significant scale in a cost-effective manner, and can be delivered off-the-shelf for patient treatment.This is of vital important and underlies one of the most solid principles and regulations of modern pharmacy.